Tag: CORO
Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19
Venous thromboembolism found in 7.9 percent of non-ICU patients, 22.7 percent of ICU patients
White House Approves Tougher Rules for COVID-19 Vaccine Development
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Six States Set Records for COVID-19 Hospitalizations
Wyoming's 36.7 percent increase since last week in its rolling seven-week average was the largest of any state
Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
Pandemic-Induced Impairments in Work Impact Mental Health
Impairments in work and social functioning strongly linked with elevated depression, anxiety symptoms
Loss of Smell Prevalent in Those With SARS-CoV-2 Antibodies
Presence of SARS-CoV-2 antibodies 2.86-fold more likely in those with loss of smell versus loss of taste
Daily COVID-19 Cases in U.S. Highest in Months
Decline seen in just three states: Texas, Missouri, and South Carolina
